| Code | 5039C | ||||||||||
| MA number | 73/0232/17-S | ||||||||||
| Product Form: | tbl flm 3x5 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Neuraxpharm Bohemia s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 73 - SPASMOLYTICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 07.09.2017 |
| PIL: |
PIL_Solifenacin Farmax_tbl flm_07_2022.pdf
|
| SPC: |
SPC_Solifenacin Farmax tbl flm_07_2022.pdf
|
| Safety feature | Yes |
| Data update: | 08.08.2022 |
